4//SEC Filing
Charlton Ralph William III 4
Accession 0001209191-22-022108
CIK 0001683553other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 8:04 PM ET
Size
5.8 KB
Accession
0001209191-22-022108
Insider Transaction Report
Form 4
Charlton Ralph William III
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-04-01+250,000→ 250,000 totalExercise: $2.13Exp: 2032-03-31→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The shares subject to the stock option vest over a four-year period commencing on the vesting commencement date of March 28, 2022 ("Vesting Commencement Date"). 1/4th of the total number of shares will vest and become exercisable on the first anniversary of the Vesting Commencement Date, and 1/36th of the remaining shares will vest and become exercisable on a monthly basis thereafter, subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2020 Equity Incentive Plan).
Documents
Issuer
SPRUCE BIOSCIENCES, INC.
CIK 0001683553
Entity typeother
Related Parties
1- filerCIK 0001919397
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 8:04 PM ET
- Size
- 5.8 KB